Detalhe da pesquisa
1.
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
J Pathol
; 253(2): 234-245, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140857
2.
Assessment of the functional impact on the pre-mRNA splicing process of 28 nucleotide variants associated with Pompe disease in GAA exon 2 and their recovery using antisense technology.
Hum Mutat
; 40(11): 2121-2130, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31301153
3.
Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in mice.
NPJ Breast Cancer
; 10(1): 5, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184660
4.
miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC.
EMBO Mol Med
; 13(7): e12872, 2021 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34062049
5.
Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer.
Cancer Res
; 80(5): 1064-1077, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31862778
6.
Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulation.
Cancer Commun (Lond)
; 43(7): 844-849, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37337406